Johannes Elferich to Protein Kinase Inhibitors
This is a "connection" page, showing publications Johannes Elferich has written about Protein Kinase Inhibitors.
Connection Strength
0.033
-
Hosseini MM, Kurtz SE, Abdelhamed S, Mahmood S, Davare MA, Kaempf A, Elferich J, McDermott JE, Liu T, Payne SH, Shinde U, Rodland KD, Mori M, Druker BJ, Singer JW, Agarwal A. Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia. 2018 11; 32(11):2374-2387.
Score: 0.033